Why the study?
Do baseline ECG markers predict and distinguish the future risk of HFrEF versus HFpEF in individuals free of cardiovascular disease?
Population
6,664 participants from MESA who were free of cardiovascular disease at baseline, 53% female, mean age 62±10…
Design
Cohort
Follow-up
median 12.1 years
Authors
Loading...
ECG markers may stratify future HFrEF versus HFpEF risk; leaves open added predictive value in primary prevention.
Do baseline ECG markers predict and distinguish the future risk of HFrEF versus HFpEF in individuals free of cardiovascular disease?
Baseline ECG markers of ventricular repolarization and delayed ventricular activation can distinguish between the future risk of developing HFrEF versus HFpEF in individuals without baseline cardiovascular disease.
O’Neal et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: